Compare APGE & AX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APGE | AX |
|---|---|---|
| Founded | 2022 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.8B |
| IPO Year | 2023 | 2005 |
| Metric | APGE | AX |
|---|---|---|
| Price | $77.22 | $85.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $100.00 | $97.07 |
| AVG Volume (30 Days) | ★ 818.6K | 284.9K |
| Earning Date | 11-10-2025 | 01-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.44 |
| Revenue | N/A | ★ $1,202,571,000.00 |
| Revenue This Year | N/A | $16.70 |
| Revenue Next Year | N/A | $9.76 |
| P/E Ratio | ★ N/A | $11.48 |
| Revenue Growth | N/A | ★ 6.69 |
| 52 Week Low | $26.20 | $54.46 |
| 52 Week High | $78.12 | $93.84 |
| Indicator | APGE | AX |
|---|---|---|
| Relative Strength Index (RSI) | 73.47 | 61.35 |
| Support Level | $74.48 | $84.52 |
| Resistance Level | $76.87 | $86.87 |
| Average True Range (ATR) | 3.37 | 2.26 |
| MACD | -0.06 | 0.43 |
| Stochastic Oscillator | 91.13 | 79.84 |
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.